Join us for a symposium on state-of-the-art in-silico engineering practices and pertinent Food and Drug Administration (FDA) compliance affairs.
96% percent of the top 50 healthcare companies in the world are using engineering simulation and computer-based models routinely. Leading medical device and pharmacutical companies are realizing that a large fraction of their engineering force should be using simulation regularly.
Simulation assisted Food And Drug Administration (FDA) approval brings new products to patients faster. In-silico testing of new prototypes on a large cohort of patients, representing the target population, reduces the need for extensive clinical trials. Patient safety is thus greatly vitalized by the adaption of in-silico computational modeling and simulation (CM&S) techniques.
Besides medicla devcie developement, CM&S is being extensively used to improve the pharmacutical process design and developelment. More specifically, engineering simulation can predict fluid flow patterns, mixing characteristics, and heat/mass transfer, behaviour of various (bio)pharmaceutical unit operations, including fermentation, crystallization, and spray drying, to name only a few.
Early adapters of this phenomenal technology shift have been experiencing a surge of benefits in terms of reduced prototype costs and saving time to market. Join us for one day seminar where industry leaders talk about best proactices in using computational modeling and simulation (CM&S) for modeling pharmacutical processes and medical devices developement.
- Key note – Engineering simulation and FDA regulatory approvals
- Trends in simulation usage in healthcare industry
- Scale-up studies for Active Pharmaceutical Ingredient (API) manufacturing
- Accelerating Scale-Up using simulation methods
- Drug formulation and medical packaging
- Case studies – Spray drying, High Shear Wet Granulation, Tablet coating
- Simulating agglomeration/nucleation
- Blow molding and thermoforming simulations for medical packaging
- Medical device and Implants:
- Simulation of cardiovascular and respiratory drug delivery
- Case Study: Metered Dosage and Dry Powder Inhaler design
- Stent, Orthopaedics implants
- Multiphysics simulations for the medical industry:
- EMI/EMC studies for medical devices
- In-silico clinical trials with human body computational models
- Human heart modelling
- Respiratory Computational Fluid Dynamics
- Scale up, Upstream and downstream process modelling
- Acceleration of New Product Introductions (NPI)
- FDA and FCC regulatory norms for in-silico testing
- In-silico (virtual) clinical trials
- Elegant numerical modelling approaches to reduce prototype costs
Who should attend this event?
- CXO, HOD executives from Pharma and Healthcare units
- Technologists from R&D and manufacturing teams in Pharma, Healthcare and Chemical processing sectors
- Simulation engineers and laboratory application engineers
- Professionals from Pharma Contract Research Organizations (CROs)
- Medical device design engineers